Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study

Published:2016-02-05 Issue:2 Volume:173 Page:274-282
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Illidge Tim M.¹,McKenzie Hayley S.²,Mayes Sam¹,Bates Andrew²,Davies Andrew J.²,Pettengell Ruth³,Stanton Louise⁴,Cozens Kelly⁴,Hampson Grace⁵,Dive Caroline⁵,Zivanovic Maureen¹,Tipping Jill¹,Gallop-Evans Eve⁶,Radford John A.¹,Johnson Peter W.M.²

Affiliation:

1. Manchester Academic Health Sciences Centre; University of Manchester; Christie NHS Foundation Trust; Manchester UK

2. NIHR/Cancer Research UK Experimental Cancer Medicine Centre; Southampton UK

3. Department of Haematology; St Georges University of London; London UK

4. Southampton Clinical Trials Unit; Southampton UK

5. Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute; The University of Manchester; Manchester UK

6. Clinical Trials Unit; Velindre Cancer Centre; Cardiff UK

Funder

Experimental Cancer Medicine Centre Funding

University Hospital Southampton NHS Foundation Trust

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13954/fullpdf

Reference27 articles.

1. Non-Hodgkin lymphoma: diagnosis and treatment;Ansell;Mayo Clinic Proceedings,2005

2. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte;Brice;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,1997

3. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,1999

4. Review of 90Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma;Emmanouilides;Cancer Management and Research,2009

5. Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma;Emmanouilides;Leukemia & Lymphoma,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives;Cancers;2022-06-19

2. Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials;Cancers;2021-11-07

3. Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis;Leukemia Research;2021-09

4. Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma;Leukemia & Lymphoma;2020-09-14

5. Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma;Leukemia & Lymphoma;2020-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3